Final ID: P3006
Pensato Umberto, Demchuk Andrew, Hill Michael, Ospel Johanna, Bosshart Salome, Stebner Alexander, Rohr Axel, Kleinig Timothy, Gupta Rishi, Thomalla Gotz, Heo Ji, Goyal Mayank
ALPACAR Phase 2 Trial of Zerlasiran: Multiple doses of a Small-Interfering RNA Targeting Lipoprotein(a) with 60 weeks Folow Up.Nissen Steven, Dorresteijn Jannick, Fok Henry, Rider David, Romano Steve, Wolski Kathy, Rambaran Curtis, Wang Qiuqing, Nicholls Stephen, Navar Ann Marie, Ray Kausik, Schwartz Gregory, Szarek Michael, Stroes Erik, Troquay Roland